News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
312 Results
Type
Article (4)
Press Release (308)
Section
Business (161)
Deals (26)
Drug Development (19)
Job Trends (2)
News (197)
Policy (7)
Tag
Alliances (63)
Artificial intelligence (1)
Best Places to Work (1)
Cancer (1)
Clinical research (9)
Diagnostics (1)
Drug discovery (1)
Earnings (75)
Events (51)
Generative AI (1)
Healthcare (1)
Inflammatory bowel disease (2)
IPO (23)
Job creations (1)
Lung cancer (1)
Mergers & acquisitions (3)
Opinion (1)
People (19)
Phase 1 (7)
Phase 2 (2)
Preclinical (8)
Real estate (2)
Regulatory (7)
Reports (1)
Startups (1)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (2)
2026 (1)
2025 (1)
2024 (14)
2023 (25)
2022 (32)
2021 (22)
2020 (27)
2019 (31)
2018 (7)
2017 (16)
2016 (7)
2015 (11)
2014 (8)
2013 (18)
2012 (11)
2011 (11)
2010 (9)
Location
Asia (262)
Australia (22)
China (1)
Europe (12)
South America (1)
312 Results for "evogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
Business
Evogene Reports First Quarter 2024 Financial Results
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter period ended March 31, 2024.
May 23, 2024
·
18 min read
Business
Evogene Schedules First Quarter 2024 Financial Results Release
Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development, announced that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024.
May 9, 2024
·
2 min read
Business
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Evogene Ltd. today announced its financial results for the fourth quarter and full-year period ending December 31, 2023.
March 7, 2024
·
19 min read
Business
Evogene Reports Third Quarter 2023 Financial Results
Evogene Ltd today announced its financial results for the third quarter period ended September 30, 2023.
November 15, 2023
·
18 min read
Business
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Evogene Ltd announced today that it will release its financial results for the third quarter of 2023 on Thursday, March 7th, 2024.
February 26, 2024
·
2 min read
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - March 20, 2024
Evogene Ltd. reported that the Company received a letter from the Nasdaq Stock Market LLC, indicating that the Company is currently not in compliance with Nasdaq Rule 5550, as the Company’s closing bid price for its ordinary shares has been below $1.00 per share for the last 30 consecutive business days.
March 20, 2024
·
5 min read
Business
Evogene Reports Second Quarter 2023 Financial Results
Evogene Ltd. today announced its financial results for the second quarter period ended June 30, 2023.
August 17, 2023
·
18 min read
Business
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
Evogene Ltd. announced that it will release its financial results for the third quarter of 2023, on Wednesday, November 15, 2023.
November 2, 2023
·
2 min read
Business
Evogene Reports First Quarter 2023 Financial Results
Evogene Ltd. today announced its financial results for the first quarter period ending March 31, 2023.
May 18, 2023
·
16 min read
1 of 32
Next
